-$0.53 EPS Expected for Scpharmaceuticals Inc (SCPH) This Quarter
Equities analysts predict that Scpharmaceuticals Inc (NASDAQ:SCPH) will post ($0.53) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for Scpharmaceuticals’ earnings. The lowest EPS estimate is ($0.56) and the highest is ($0.49). The firm is expected to issue its next quarterly earnings results on Monday, January 1st.
On average, analysts expect that Scpharmaceuticals will report full-year earnings of ($2.12) per share for the current year, with EPS estimates ranging from ($2.23) to ($2.01). For the next year, analysts forecast that the business will report earnings of ($2.75) per share, with EPS estimates ranging from ($2.90) to ($2.60). Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research firms that cover Scpharmaceuticals.
SCPH has been the subject of several research reports. BMO Capital Markets initiated coverage on Scpharmaceuticals in a report on Tuesday, December 12th. They set an “outperform” rating and a $24.00 price target for the company. Leerink Swann initiated coverage on Scpharmaceuticals in a report on Tuesday, December 12th. They set an “outperform” rating and a $20.00 price target for the company. Jefferies Group initiated coverage on Scpharmaceuticals in a report on Tuesday, December 12th. They set a “buy” rating and a $23.00 price target for the company. Finally, Zacks Investment Research lowered Scpharmaceuticals from a “hold” rating to a “sell” rating in a report on Wednesday, February 14th.
Shares of Scpharmaceuticals (NASDAQ:SCPH) opened at $15.36 on Friday. Scpharmaceuticals has a 1-year low of $11.50 and a 1-year high of $18.17.
TRADEMARK VIOLATION WARNING: “-$0.53 EPS Expected for Scpharmaceuticals Inc (SCPH) This Quarter” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.watchlistnews.com/0-53-eps-expected-for-scpharmaceuticals-inc-scph-this-quarter/1904324.html.
scPharmaceuticals, Inc, is a biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Scpharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scpharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.